%0
Generic
%T
Growth modulation index (GMI) as a metric of clinical benefit assessment among advanced soft tissue sarcoma (ASTS) patients receiving trabectedin as salvage therapy.
%A Penel, Nicolas
%A Demetri, George D.
%A Blay, Jean-Yves
%A Cousin, Sophie
%A Maki, Robert G.
%A Chawla, Sant P.
%A Judson, Ian Robert
%A von Mehren, Margaret
%A Schoffski, Patrick
%A Verweij, Jaap
%A Casali, Paolo Giovanni
%A Rodenhuis, Sjoerd
%A Gomez, Javier
%A Nieto, Antonio
%A Zintl, Patrik
%A Pontes Valero, Maria Jose
%A Cassar, Alexia
%A Le Cesne, Axel
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2012
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2